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30
A central goal of biology is to understand how DNA, the primary sequence, gives rise to observable traits.
31
Historically, much effort has gone into deciphering the primary sequence of eukaryotes, primarily Homo 32 sapiens. As of August 8, 2014, the National Human Genome Research Institute (NHGRI) reported 1,961 33 publications of genome-wide association studies (GWAS). Within these studies, a total of 14,014 single 34 nucleotide polymorphisms (SNPs) are associated with over 600 phenotypes. The advent of GWAS in 35 bacteria has mainly occurred in the last two years [1**, 2**, 3**, 4**, 5**, 6**], and provides an 36 unbiased "top-down" framework [7] to dissect the genetic basis of bacterial phenotypes. In principle, any 37 measurable bacterial phenotype (or archaeal phenotype, although here our focus is on bacteria) can be 38 dissected with a GWAS approach. To date, bacterial GWAS have focused on clinically-relevant 39 phenotypes such as virulence and antibiotic resistance, but there is also great potential to investigate 40 environmentally or industrially relevant phenotypes as well.
42
Bacterial genomes experience strong linkage, strong stratification and strong selection 43 Are bacterial genetic mapping studies any different from eukaryotic studies? Although there are many 44 fundamental differences, this review highlights three features that are most germane to GWAS. The 45 impact of the first two differences, in linkage and population stratification, have been recognized before 46 [6**, 7], but we identify the strength of natural selection relative to drift as a third and under-appreciated 47 factor to consider in bacterial GWAS. 48 49 First, unlike eukaryotic recombination which occurs predominantly via the crossing-over of two 50 homologous chromosomes during meiosis, bacterial recombination occurs via gene conversion of 51 relatively short stretches of DNA. In bacteria, recombination is not coupled with reproduction, and can 52 occur multiple times within a cell's lifespan, or not at all. Without any recombination, purely clonal 53 transmission of DNA leaves the entire bacterial chromosome in complete linkage (in strong linkage 54 disequilibrium; LD). As with eukaryotic genomes, bacterial recombination events break this linkage, but 55 4 the landscape of LD is markedly different from that seen in eukaryotes; gene conversion events leave a 56 "patchwork" of recombined tracts on top of a genomic background of linked regions called a clonal frame 57 [8] . In contrast to eukaryotic LD patterns, all regions of the clonal frame are in complete linkage, and 58 these regions may be quite distant from one another. The clonal frame phenomenon limits the utility of 59 classic genetic mapping methods mainly by obscuring the true causal variant from the rest of the linked 60 sites in the clonal frame. Here, we define a variant as causal if it plays a functional role in the phenotype 61 of interest, as opposed to only being correlated with the phenotype. 62 63 Second, as with eukaryotes, bacterial genomic diversity may be shaped by population stratification.
64
Stratification refers to a "situation in which the population of interest includes subgroups of individuals 65 that are on average more related to each other than to other members of the wider population" [9]. These 66 subpopulations give rise to spurious associations when "cases" (with phenotype A) are on average more 67 closely related with each other than with "controls" (without phenotype A); in other words, associations 68 due to genetic relatedness rather than causality for the phenotype of interest. The problem of population 69 stratification is particularly acute in highly clonal (rarely recombining) bacteria, and in those with 70 separate geographic or host-associated subpopulations [6**].
72
Third, the phenotypes of most interest in bacterial GWAS are largely different from many human disease 73 phenotypes. In particular, bacterial phenotypes tend to be shaped by strong natural selection (e.g. positive 74 directional selection driving drug resistance), while many human disease phenotypes evolve largely by 75 genetic drift owing to historically small effective population sizes (e.g. due to population bottlenecks); in 76 this scenario, drift overpowers purifying selection and leaves slightly deleterious alleles in the population 77 that underlie disease traits [10, 11] . This is not to say that bacteria do not experience genetic drift 78 (particularly in frequently bottlenecked populations), but simply that many traits of interest (e.g. clusters as covariates reduced the inflation factor to 1, suggesting that it effectively controls for 164 population stratification (Figure 2c ). Although this procedure clearly changes the Manhattan plot ( Figure   165 2, right panels), producing more clean 'hits' that stand out from the average p-value, we note that none of 166 these hits pass correction for multiple hypothesis testing. Therefore, correcting for population 167 stratification can reduce GWAS power significantlya problem that could potentially be overcome by 168 using larger sample sizes (e.g. thousands rather than hundreds of genomes; [5**]).
170
Comparison of GWAS against convergence testing 171 Despite the lack of significance after multiple testing correction, we identified 133 potential GWAS hits 172 (SNPs) in 77 genes that stood out as outliers from the average genome-wide p-value (Figure 2c ), which 173 we will discuss for illustration purposes. These GWAS hits overlapped with 5 of 11 previously known 174 'gold standard' resistance genes and 22 of 46 additional phyC candidate resistance genes. It is also 175 evident that correcting for population stratification improves the overlap with known resistance genes and 176 phyC hits (Figure 3 
